<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Electron Physician</journal-id><journal-id journal-id-type="iso-abbrev">Electron Physician</journal-id><journal-id journal-id-type="publisher-id">Electronic physician</journal-id><journal-title-group><journal-title>Electronic Physician</journal-title></journal-title-group><issn pub-type="epub">2008-5842</issn><publisher><publisher-name>Electronic physician</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26120393</article-id><article-id pub-id-type="pmc">4477779</article-id><article-id pub-id-type="doi">10.14661/2013.623-630</article-id><article-id pub-id-type="publisher-id">epj-05-623</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Effect of six-week aerobic exercise on Chemerin and Resistin concentration in hypertensive postmenopausal women</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Aghapour</surname><given-names>Atieh</given-names></name><xref ref-type="aff" rid="af1-epj-05-623"><sup>1</sup></xref><xref ref-type="corresp" rid="c1-epj-05-623"/></contrib><contrib contrib-type="author"><name><surname>Farzanegi</surname><given-names>Parvin</given-names></name><xref ref-type="aff" rid="af2-epj-05-623"><sup>2</sup></xref></contrib><aff id="af1-epj-05-623"><label>1:</label>Department of Exercise Physiology, Science and Research Branch, Islamic Azad University, Mazandaran, Iran</aff><aff id="af2-epj-05-623"><label>2:</label>Assistant Professor of Sport Physiology, Department of Sport Physiology, Science and Research Branch, Islamic Azad University, Mazandaran, Iran</aff></contrib-group><author-notes><corresp id="c1-epj-05-623">Corresponding Author: Atieh Aghapour, Department of Sport Physiology, Science and Research Branch, Islamic Azad University, Mazandaran, Iran. Tel: +98.1512223590, E-Mail: <email>Atieh_aghapour@yahoo.com</email></corresp></author-notes><pub-date pub-type="collection"><season>Jan-Mar</season><year>2013</year></pub-date><pub-date pub-type="epub"><day>01</day><month>2</month><year>2013</year></pub-date><volume>5</volume><issue>1</issue><fpage>623</fpage><lpage>630</lpage><permissions><copyright-statement>&#x000a9; 2013 The Authors</copyright-statement><copyright-year>2013</copyright-year><license><license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">Creative Commons Attribution-NonCommercial-NoDerivs License</ext-link>, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.</license-p></license></permissions><abstract><sec><title>Background:</title><p>Physical activity reduces symptoms of cardiovascular diseases. The aim of this study was to examine the effect of six-week aerobic exercise upon Chemerin and Resistin concentration in women with menopause who had hypertension.</p></sec><sec><title>Methods:</title><p>The population of this quasi-experimental study included postmenopausal women diagnosed with hypertension. They were 50 to 55 years old and lived in Amol, a city in north part of Iran. Twenty volunteers were filled the personal consent and Health Questionnaire. They were randomly assigned to Experimental and control groups equally (n=10 per group). The experimental group conducted a 6-week aerobic training program from 8&#x02013;10am every day.</p></sec><sec><title>Results:</title><p>Endurance exercise decreased Chemerin (t=10.41, P&#x0003c;0.000) and Resistin (t=2.42, P&#x0003c;0.051); indicating the decline of inflammation and cardiovascular disease.</p></sec><sec><title>Conclusion:</title><p>Considering anti-inflammatory effects of exercise, training plays an important role in reducing inflammatory indices in human; and endurance training can be a good strategy to deal with inflammation and cardiac- vascular risk factors.</p></sec></abstract><kwd-group><kwd>Aerobic exercise</kwd><kwd>Chemerin</kwd><kwd>Resistin</kwd><kwd>Postmenopausal</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><label>1.</label><title>Introduction</title><p>Nearly 233 percent growth in 2025 is expected to be in the world&#x02019;s elderly population- the majority are women (<xref rid="b1-epj-05-623" ref-type="bibr">1</xref>). Menopause is not a disease, but is associated with many physical and psychological problems (<xref rid="b2-epj-05-623" ref-type="bibr">2</xref>). Studies show that the incidence of some diseases such as hypertension in women increases after menopause (<xref rid="b3-epj-05-623" ref-type="bibr">3</xref>, <xref rid="b4-epj-05-623" ref-type="bibr">4</xref>). Hypertension is a global problem; a disease that is asymptomatic and often called the silent killer (<xref rid="b5-epj-05-623" ref-type="bibr">5</xref>). According to the World Health Organization, hypertension is the third leading cause of mortality in humans worldwide (<xref rid="b6-epj-05-623" ref-type="bibr">6</xref>). Studies show that the treatment and control of hypertension reduce the risk of cardiovascular diseases and their complications (<xref rid="b7-epj-05-623" ref-type="bibr">7</xref>). In addition to beneficial effect on blood pressure, regular exercise reduces cholesterol and body fat and diseases such as arteriosclerosis (blocked arteries) (<xref rid="b8-epj-05-623" ref-type="bibr">8</xref>). In addition to hyper cholesterolemia, the factors such as diabetes, smoking, inactivity, obesity, and hypertension are known as the risk factors in arteriosclerosis disease (<xref rid="b9-epj-05-623" ref-type="bibr">9</xref>).</p><p>Resistin as an important inflammatory marker has a role in trauma and the development of arteriosclerosis and it has direct relationship with the risk of arteriosclerosis and High Sensitive C-reactive protein (<xref rid="b10-epj-05-623" ref-type="bibr">10</xref>, <xref rid="b11-epj-05-623" ref-type="bibr">11</xref>, and <xref rid="b12-epj-05-623" ref-type="bibr">12</xref>). The reports show that Epicardial adipose tissue plays an important role in pathogenesis and the progression of Coronary artery disease with creating inflammatory adipocytokine. The Chemerin is a recently discovered Chemokine (<xref rid="b13-epj-05-623" ref-type="bibr">13</xref>) found in the liver and white adipose tissue (<xref rid="b14-epj-05-623" ref-type="bibr">14</xref>), and is associated with obesity, hypertension, inflammation and arteriosclerosis (<xref rid="b15-epj-05-623" ref-type="bibr">15</xref>). Little research has been done regarding the effects of aerobic exercise on plasma Resistin; all show that regular aerobic activity can reduce levels of Resistin in human (<xref rid="b16-epj-05-623" ref-type="bibr">16</xref>, <xref rid="b17-epj-05-623" ref-type="bibr">17</xref>). The result of studies also suggests that regular aerobic exercise has reduced Chemerin levels, body mass index and blood pressure (<xref rid="b18-epj-05-623" ref-type="bibr">18</xref>, <xref rid="b19-epj-05-623" ref-type="bibr">19</xref>, <xref rid="b20-epj-05-623" ref-type="bibr">20</xref>). In addition, little research has been done about the effects of aerobic exercise on Resistin and Chemerin concentrations in postmenopausal women. Therefore, due to the little information on the effects of regular physical activity on menopausal women, this study investigated the effect of 6 weeks of regular aerobic activity on Chemerin and Resistin levels of postmenopausal women &#x02013;who had hypertension disease.</p><p>The results of a study reported 15 % prevalence of hypertension in women over 18 years of Zabol in 2002 (<xref rid="b21-epj-05-623" ref-type="bibr">21</xref>). Also, the mean systolic blood pressure in people over 18 years old in Mashhad has been 17.97&#x000b1;122.40 in 2005 (<xref rid="b22-epj-05-623" ref-type="bibr">22</xref>). In recent decades, the researchers have emphasized on the effects of aerobic exercise on cardiovascular risk factors (<xref rid="b23-epj-05-623" ref-type="bibr">23</xref>, <xref rid="b24-epj-05-623" ref-type="bibr">24</xref>). There is also substantial information indicating that regular aerobic activity prevents the structural and functional abnormalities of the limbs (<xref rid="b25-epj-05-623" ref-type="bibr">25</xref>) and reduces the development of blood pressure (<xref rid="b26-epj-05-623" ref-type="bibr">26</xref>). In research conducted in this field, the decrease of blood pressure in people with hypertension followed by regular physical activity has been reported approximately 7.5 ml of mercury (<xref rid="b27-epj-05-623" ref-type="bibr">27</xref>).</p><p>Through impairment of glucose and lipid metabolism, Resistin may increase plaque vulnerability by stimulating pro-inflammatory cytokines (<xref rid="b28-epj-05-623" ref-type="bibr">28</xref>). In some studies, men showed no significant change in the Resistin level up to 48 hours after aerobic exercise (<xref rid="b29-epj-05-623" ref-type="bibr">29</xref>); while in others studies, regular aerobic exercise has shown good results in reducing the concentration of Resistin (<xref rid="b30-epj-05-623" ref-type="bibr">30</xref>). Some research showed (<xref rid="b31-epj-05-623" ref-type="bibr">31</xref>, <xref rid="b32-epj-05-623" ref-type="bibr">32</xref>) but some studies did not show (<xref rid="b33-epj-05-623" ref-type="bibr">33</xref>&#x02013;<xref rid="b35-epj-05-623" ref-type="bibr">35</xref>). Chemerin is an important factor for Adiposyte process and state regulation of genes involved in glucose and lipid balance (<xref rid="b36-epj-05-623" ref-type="bibr">36</xref>). It has been reported that in Adipocytes, Chemerin enhances the insulin-stimulated glucose and causes the phosphorylation of tyrosine in Insulin receptor substrate. According to the studies, Chemerin may increase insulin sensitivity in adipose tissue and is largely associated with Body mass index, triglycerides, and blood pressure in those with normal glucose tolerance (<xref rid="b37-epj-05-623" ref-type="bibr">37</xref>). Studies showed that Chemerin levels were contributed to adipose tissue and skeletal muscle and is negatively related to obesity and insulin sensitivity (<xref rid="b38-epj-05-623" ref-type="bibr">38</xref>). The results also show the impact of aerobic exercise on improved cardiovascular and metabolic risk factors in obese people and reduced amount of Chemerin (<xref rid="b39-epj-05-623" ref-type="bibr">39</xref>).</p><p>Other research also suggests a significant impact of sport and physical activity on blood pressure (<xref rid="b40-epj-05-623" ref-type="bibr">40</xref>). Although the effect of aerobic exercise on Resistin and Chemerin concentration in postmenopausal women is unknown, the results of many studies suggest lowering effect of exercise on blood pressure; so walking and cycling have been known as other positive factors in the regulation of blood pressure (<xref rid="b41-epj-05-623" ref-type="bibr">41</xref>). Augustine Sohn examined the effects of exercise (walking) in a large population of African-Americans with high blood pressure. That study was performed on 19 patients in two groups: Work and control group. They showed that more than 30 minutes of walking in a day reduces blood pressure in African-American adults who have high blood pressure (<xref rid="b42-epj-05-623" ref-type="bibr">42</xref>). Exercise is the basis of health in individuals &#x02013;regardless of age, sex or group. Individuals in each age or sexual group should have activity and mobility; it is more important, especially in high-risk populations (<xref rid="b43-epj-05-623" ref-type="bibr">43</xref>). In this study, the followings set as the specific objectives of the study: 1) To determine the effect of a six-week regular activity and exercise on the Resistin level in postmenopausal women, 2) To determine the effect of a six-week regular activity and exercise on the Chemerin level in postmenopausal women, and 3) To determine the relation between Chemerin and Resistin level in postmenopausal women before and after six weeks of aerobic activity.</p></sec><sec sec-type="materials|methods"><label>2.</label><title>Material and Methods</title><sec sec-type="methods"><label>2.1.</label><title>Study design and sampling</title><p>This study was a quasi-experimental research with a pre-post test design. The population of this study included postmenopausal women diagnosed with hypertension; they were 50 to 55 years old and from Amol, a city in Mazandaran province, Iran. After required examination and verification of high pressure by the physician, 20 volunteers were selected through a purposive sampling. Participants completed a questionnaire indicating the lack of sports history during the past six months, the lack of anti-hypertension drugs use, hormone therapy, cardiovascular problems, and complete stoppage of menstrual cycle.</p><p>Filling out the personal consent and Health Questionnaire, subjects were randomly assigned to two equal groups (n=10 per group): Experimental and Control groups. The experimental group conducted a 6-week aerobic training program at 8 to 10 am. The control group did not participate in any training program. In this study, ethical considerations included the complete description of the objectives to the study participants, ensuring the confidentiality of their information.</p></sec><sec><label>2.2.</label><title>Experiment</title><p>The aerobic exercise program of experimental group consisted of 6 weeks aerobic exercise, three times a week for 45 minutes at 50 percent maximum heart rate reserve during the first week and 60 minutes of exercise at the sixth week with 60% of maximum heart rate; thus, every two weeks, 5% was added to the intensity of aerobic activity. The aerobic activity included a 10 minutes warm-up such as stretching, exercise and running, 30 to 45 minutes main training exercises and 10 minutes cool-down exercises. The subjects were also advised to refuse any other exercise during the six-week program.</p></sec><sec sec-type="methods"><label>2.3.</label><title>Data collection</title><sec><label>2.3.1.</label><title>Heart rate measurement</title><p>Using a stethoscope, heart rate was controlled during the aerobic exercise. The participants&#x02019; maximum heart rate was calculated using equation (Age - 220).</p></sec><sec><label>2.3.2.</label><title>Blood Pressure Measurement</title><p>The systolic and diastolic BP of participants in the experimental group was measured before and after 6 weeks of exercise training in different circumstances in a sitting position using a mercury sphygmomanometer based on guidelines.</p></sec><sec><label>2.3.3.</label><title>Height Measurement</title><p>The height was measured in the morning using the height gauge with an accuracy of 0.1 &#x000b1; cm in the standing position without shoes, while the shoulders were in a normal condition.</p></sec><sec><label>2.3.4.</label><title>Measurement of body weight</title><p>Weight was measured using a German digital scale with a 0.1 &#x000b1; kg precision with minimal clothing without shoes. Body mass index (BMI) was calculated by dividing weight (kg) by height (in meters).</p></sec><sec><label>2.3.5.</label><title>Blood sampling method</title><p>To examine variables, blood sampling was done on two stages: before the start of training and the sixth week. Subjects were instructed to refuse any exercise and eat light foods 24 hours before phlebotomy. Blood samples were taken of experimental and control groups after 12 hours of fasting in pre-test stage and 48 h after the last training session on the post test stage. For plasma separation, blood samples were centrifuged at the speed of 3000 rpm for 15 min and were frozen at 80 - &#x000b0; C, and stored for subsequent analysis.</p></sec><sec sec-type="methods"><label>2.3.6.</label><title>Biochemical analysis</title><p>Measurement was done using a commercial ELISA kit according to the manufacturer&#x02019;s instruction.</p></sec></sec><sec sec-type="methods"><label>2.4.</label><title>Statistical methods</title><p>Kolmogorov-Smirnov and Levin test were used for determining the normal distribution of data and homogeneity of variances, respectively. Both dependent and independent t-tests were used to investigate the changes in the intra-group and the differences in inter-group of variables. Statistical operations were performed using SPSS 15 and the significance level of the tests was considered at P&#x0003c;0.05.</p></sec></sec><sec sec-type="results"><label>3.</label><title>Results</title><p>The mean age of the participants was 54 years (&#x000b1;3.75). <xref ref-type="table" rid="t1-epj-05-623">Table 1</xref> shows the general characteristics of subjects in each group. The data shows that at the beginning of research, there was no significant difference between the values for age, height and body weight between the groups. Then the groups were homogeneous.</p><p>The results in <xref ref-type="table" rid="t2-epj-05-623">Table 2</xref> show that the lowest concentration of Chemerin in the experimental group was after six weeks of aerobic activity was 250.66 pg/ ml and the highest concentration of Chemerin in this group was 337.48 pg/ ml. According to our findings, the lowest concentration of Chemerin in the control group after six weeks of aerobic activity was 343.70 pg ml and the highest concentration of Chemerin in this group was 348.99 pg/ml. Six weeks growing aerobic exercise has no significant effect on Chemerin concentrations in postmenopausal women. The data in <xref ref-type="table" rid="t3-epj-05-623">Table 3</xref> shows that the obtained t is smaller than table&#x02019;s t (t=2.44); There was no significant difference between Chemerin concentrations in postmenopausal women before and after a period of six weeks (P&#x0003e;0.160).</p><p>Data in <xref ref-type="table" rid="t3-epj-05-623">Table 3</xref> shows that the obtained t is greater than table&#x02019;s t (t=2.14) and there was significant difference between the Chemerin level in exercise and control groups (P &#x0003c; 0.05). The data in <xref ref-type="table" rid="t3-epj-05-623">Table 3</xref> shows that the obtained t is smaller than table&#x02019;s t (t=2.44); There was no significant difference between Resistin concentrations in postmenopausal women before and after a period of six weeks (P&#x0003e;0.051). <xref ref-type="table" rid="t3-epj-05-623">Table 3</xref> also shows that the obtained t is smaller than table&#x02019;s t (t=2.44); There was no significant difference between Resistin concentrations in postmenopausal women before and after a period of six weeks (P&#x0003e;0.625). As it is illustrated in the <xref ref-type="table" rid="t4-epj-05-623">table 4</xref>, the obtained t is smaller than table&#x02019;s t (t=2.14); There was no significant difference between Resistin concentrations in postmenopausal women before and after a period of six weeks (P&#x0003e;0.05). <xref ref-type="table" rid="t5-epj-05-623">Table 5</xref> shows that there is no significant correlation between Resistin and Chemerin changes in treatment group. It also says there is no significant correlation between Resistin and Chemerin changes in exercise group.</p></sec><sec sec-type="discussion"><label>4.</label><title>Discussion</title><p>The results of this study show that endurance exercise decreases Chemerin and Resistin indicating the decline of inflammation and cardiovascular disease. The results are consistent with the earlier results showing regular aerobic activity can reduce levels of Resistin in human (<xref rid="b16-epj-05-623" ref-type="bibr">16</xref>, <xref rid="b21-epj-05-623" ref-type="bibr">21</xref>). However, further studies on the effects of long term exercise on Chemerin and Resistin are required. Considering anti-inflammatory effects of exercise, training plays an important role in reducing inflammatory indices in human; and endurance training can be a good strategy to deal with inflammation and cardiac- vascular risk factors. This study pointed out that 6 weeks of aerobic exercise significantly reduced blood pressure in postmenopausal women with hypertension. Then, at the end of the sixth week of aerobic exercise, heart rate in postmenopausal women has increased. The results are consistent with the earlier studies (<xref rid="b1-epj-05-623" ref-type="bibr">1</xref>, <xref rid="b9-epj-05-623" ref-type="bibr">9</xref>). However, period of this study and training programs was short and more evidence is required to confirm the long-term effects of exercise.</p></sec><sec><label>5.</label><title>Conclusion</title><p>In summary, results showed that six weeks of aerobic exercise training significantly decreased Resistin, Chemerin, and blood pressure in postmenopausal women. Therefore, aerobic exercise can be used as a non-pharmacologic method to improve the health of patients with coronary artery disease and hypertension. Paying more attention to all segments of society, especially the elderly and putting a light and a regular exercise program for patients with hypertension may increase the health status of the vulnerable elderly population.</p></sec></body><back><ack><p>The authors would like to extend their gratitude to the Dr. Farzanegi for her invaluable support.</p></ack><fn-group><fn><p><bold>Conflict of Interest:</bold></p><p>There is no conflict of interest to be declared.</p></fn></fn-group><ref-list><title>References</title><ref id="b1-epj-05-623"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>R</given-names></name><name><surname>Peto</surname><given-names>R</given-names></name><name><surname>MacMahon</surname><given-names>S</given-names></name><name><surname>Hebert</surname><given-names>P</given-names></name><name><surname>Fiebach</surname><given-names>NH</given-names></name><name><surname>Eberlein</surname><given-names>KA</given-names></name><name><surname>Godwin</surname><given-names>J</given-names></name><name><surname>Qizilbash</surname><given-names>N</given-names></name><name><surname>Taylor</surname><given-names>JO</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name></person-group><article-title>Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context</article-title><source>Lancet</source><year>1990</year><comment>7;</comment><volume>335</volume><issue>8693</issue><fpage>827</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">1969567</pub-id></element-citation></ref><ref id="b2-epj-05-623"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Teoman</surname><given-names>N</given-names></name><name><surname>Ozcan</surname><given-names>A</given-names></name><name><surname>Acar</surname><given-names>B</given-names></name></person-group><article-title>The effect of exercise on physical fitness and quality of life in Postmenopausal women</article-title><source>Maturitas</source><year>2004</year><comment>20</comment><volume>47</volume><issue>1</issue><fpage>71</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">14706768</pub-id></element-citation></ref><ref id="b3-epj-05-623"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Casiglia</surname><given-names>Edoardo</given-names></name><name><surname>Palatini</surname><given-names>Paolo</given-names></name><name><surname>Da Ros</surname><given-names>Santina</given-names></name><name><surname>Pagliara</surname><given-names>Valeria</given-names></name><name><surname>Puato</surname><given-names>Massimo</given-names></name><name><surname>Dorigatti</surname><given-names>Francesca</given-names></name><name><surname>Pauletto</surname><given-names>Paolo</given-names></name></person-group><article-title>Effect of Blood Pressure and Physical Activity on Carotid Artery Intima&#x02013;Media Thickness in Stage 1 Hypertensives and Controls</article-title><source>Am J Hypertens</source><year>2000</year><volume>13</volume><issue>12</issue><fpage>1256</fpage><lpage>1262</lpage><pub-id pub-id-type="pmid">11130768</pub-id></element-citation></ref><ref id="b4-epj-05-623"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orshal</surname><given-names>JM</given-names></name><name><surname>Khalil</surname><given-names>RA</given-names></name></person-group><article-title>Gender, sex hormones, and vasculartone</article-title><source>Am J Physiol Regul Integr Comp Physiol</source><year>2004</year><volume>286</volume><issue>2</issue><fpage>R233</fpage><lpage>49</lpage><pub-id pub-id-type="pmid">14707008</pub-id></element-citation></ref><ref id="b5-epj-05-623"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chedraui</surname><given-names>P</given-names></name><name><surname>Blumel</surname><given-names>JE</given-names></name><name><surname>Barone</surname><given-names>G</given-names></name><name><surname>Belzares</surname><given-names>E</given-names></name><name><surname>Bencosme</surname><given-names>A</given-names></name><name><surname>Calle</surname><given-names>A</given-names></name><etal/></person-group><article-title>Impaired quality of life among middl aged women: A multicentre latino American study</article-title><source>Maturitas</source><year>2004</year><volume>47</volume><fpage>71</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">14706768</pub-id></element-citation></ref><ref id="b6-epj-05-623"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Psaltopoulou</surname><given-names>T</given-names></name><name><surname>Orfanos</surname><given-names>P</given-names></name><name><surname>Naska</surname><given-names>A</given-names></name><name><surname>Lenas</surname><given-names>D</given-names></name><name><surname>Trichopoulos</surname><given-names>D</given-names></name><name><surname>Trichopoulou</surname><given-names>A</given-names></name></person-group><article-title>Prevalence, awareness, treatment and control of hypertension in a general population sample of 26,913 adults in the Greek EPIC study</article-title><source>Int J Epidemiol</source><year>2004</year><volume>33</volume><issue>6</issue><fpage>1345</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">15218014</pub-id></element-citation></ref><ref id="b7-epj-05-623"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chobanian</surname><given-names>AV</given-names></name><name><surname>Bakris</surname><given-names>GL</given-names></name><name><surname>Black</surname><given-names>HR</given-names></name><name><surname>Cushman</surname><given-names>WC</given-names></name><name><surname>Green</surname><given-names>LA</given-names></name><name><surname>Izzo</surname><given-names>JL</given-names><suffix>Jr</suffix></name><name><surname>Jones</surname><given-names>DW</given-names></name><name><surname>Materson</surname><given-names>BJ</given-names></name><name><surname>Oparil</surname><given-names>S</given-names></name><name><surname>Wright</surname><given-names>JT</given-names><suffix>Jr</suffix></name><name><surname>Roccella</surname><given-names>EJ</given-names></name><collab>Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</collab><collab>National Heart, Lung, and Blood Institute</collab><collab>National High Blood Pressure Education Program Coordinating Committee</collab></person-group><article-title>Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure</article-title><source>Hypertension</source><year>2003</year><volume>42</volume><issue>6</issue><fpage>1206</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">14656957</pub-id></element-citation></ref><ref id="b8-epj-05-623"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kopff</surname><given-names>B</given-names></name><name><surname>jegier</surname><given-names>A</given-names></name></person-group><article-title>Adipokines: adiponectin, leptin, resistin and coronary heart disease risk</article-title><source>Przegl lek</source><year>2005</year><volume>62</volume><issue>3</issue><fpage>69</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">16521924</pub-id></element-citation></ref><ref id="b9-epj-05-623"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoefle</surname><given-names>G</given-names></name><name><surname>Saely</surname><given-names>CH</given-names></name><name><surname>Risch</surname><given-names>L</given-names></name><name><surname>Koch</surname><given-names>L</given-names></name><name><surname>Schmid</surname><given-names>F</given-names></name><name><surname>Rein</surname><given-names>P</given-names></name><name><surname>Acz&#x000e9;l</surname><given-names>S</given-names></name><name><surname>Berchtold</surname><given-names>S</given-names></name><name><surname>Drexel</surname><given-names>H</given-names></name></person-group><article-title>Relationship between the adipose-tissue hormone resistin and coronary artery disease</article-title><source>Clin Chim Acta</source><year>2007</year><volume>386</volume><issue>1&#x02013;2</issue><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">17706624</pub-id></element-citation></ref><ref id="b10-epj-05-623"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hansson</surname><given-names>GK</given-names></name></person-group><article-title>Inflammation atherosclerosis, and coronary artery disease</article-title><source>New engl J Med</source><year>2005</year><volume>352</volume><issue>16</issue><fpage>1685</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">15843671</pub-id></element-citation></ref><ref id="b11-epj-05-623"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hackam</surname><given-names>DG</given-names></name><name><surname>Anand</surname><given-names>ss</given-names></name></person-group><article-title>Emerging risk factors for atherosclerotic vascular disease:a critical review of the evidence</article-title><source>J American medical association (JAMA)</source><year>2003</year><volume>290</volume><issue>7</issue><fpage>932</fpage><lpage>40</lpage></element-citation></ref><ref id="b12-epj-05-623"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markel</surname><given-names>H</given-names></name><name><surname>Rocchini</surname><given-names>AP</given-names></name><name><surname>Beekman</surname><given-names>RH</given-names></name><name><surname>Martin</surname><given-names>J</given-names></name><name><surname>Palmisano</surname><given-names>J</given-names></name><name><surname>Moorehead</surname><given-names>C</given-names></name><name><surname>Rosenthal</surname><given-names>A</given-names></name></person-group><article-title>Exercise-Induced Hypertension After Repair of Coarctation of the Aorta: Arm Versus Leg Exercise</article-title><source>J Am Coll CardioI</source><year>1986</year><volume>8</volume><issue>1</issue><fpage>165</fpage><lpage>71</lpage></element-citation></ref><ref id="b13-epj-05-623"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wittamer</surname><given-names>V</given-names></name><name><surname>Franssen</surname><given-names>JD</given-names></name><name><surname>Vulcano</surname><given-names>M</given-names></name><name><surname>Mirjolet</surname><given-names>JF</given-names></name><name><surname>Le Poul</surname><given-names>E</given-names></name><name><surname>Migeotte</surname><given-names>I</given-names></name><name><surname>Br&#x000e9;zillon</surname><given-names>S</given-names></name><name><surname>Tyldesley</surname><given-names>R</given-names></name><name><surname>Blanpain</surname><given-names>C</given-names></name><name><surname>Detheux</surname><given-names>M</given-names></name><name><surname>Mantovani</surname><given-names>A</given-names></name><name><surname>Sozzani</surname><given-names>S</given-names></name><name><surname>Vassart</surname><given-names>G</given-names></name><name><surname>Parmentier</surname><given-names>M</given-names></name><name><surname>Communi</surname><given-names>D</given-names></name></person-group><article-title>Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids</article-title><source>J Exp Med</source><year>2003</year><comment>6</comment><volume>198</volume><issue>7</issue><fpage>977</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">14530373</pub-id></element-citation></ref><ref id="b14-epj-05-623"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bozaoglu</surname><given-names>K</given-names></name><name><surname>Bolton</surname><given-names>K</given-names></name><name><surname>McMillan</surname><given-names>J</given-names></name><name><surname>Zimmet</surname><given-names>P</given-names></name><name><surname>Jowett</surname><given-names>J</given-names></name><name><surname>Collier</surname><given-names>G</given-names></name><name><surname>Walder</surname><given-names>K</given-names></name><name><surname>Segal</surname><given-names>D</given-names></name></person-group><article-title>Chemerin is a novel adipokine associated with obesity and metabolic syndrome</article-title><source>Endocrinology</source><year>2007</year><volume>148</volume><issue>10</issue><fpage>4687</fpage><lpage>94</lpage><pub-id pub-id-type="pmid">17640997</pub-id></element-citation></ref><ref id="b15-epj-05-623"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grady</surname><given-names>D</given-names></name><name><surname>Herrington</surname><given-names>D</given-names></name><name><surname>Bittner</surname><given-names>V</given-names></name><name><surname>Blumenthal</surname><given-names>R</given-names></name><name><surname>Davidson</surname><given-names>M</given-names></name><name><surname>Hlatky</surname><given-names>M</given-names></name><name><surname>Hsia</surname><given-names>J</given-names></name><name><surname>Hulley</surname><given-names>S</given-names></name><name><surname>Herd</surname><given-names>A</given-names></name><name><surname>Khan</surname><given-names>S</given-names></name><name><surname>Newby</surname><given-names>LK</given-names></name><name><surname>Waters</surname><given-names>D</given-names></name><name><surname>Vittinghoff</surname><given-names>E</given-names></name><name><surname>Wenger</surname><given-names>N</given-names></name><collab>HERS Research Group</collab></person-group><article-title>Cardiovascular disease outcomes during 68 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow-up (HERSII)</article-title><source>J American medical association (JAMA)</source><year>2002</year><comment>3</comment><volume>288</volume><issue>1</issue><fpage>49</fpage><lpage>57</lpage></element-citation></ref><ref id="b16-epj-05-623"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jamurtas</surname><given-names>AZ</given-names></name><name><surname>theocharis</surname><given-names>v</given-names></name><name><surname>koukiulis</surname><given-names>G</given-names></name><name><surname>stakias</surname><given-names>N</given-names></name><name><surname>Fatouros</surname><given-names>IG</given-names></name><etal/></person-group><article-title>the effects of acute exercise on serum adiponectin and resistin levels and their relation to insulin sensitivity in overweight males</article-title><source>Eur J appl physiol</source><year>2006</year><volume>97</volume><issue>1</issue><fpage>122</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">16525810</pub-id></element-citation></ref><ref id="b17-epj-05-623"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TE</given-names></name><name><surname>Basilio</surname><given-names>JL</given-names></name><name><surname>Brophy</surname><given-names>PM</given-names></name><name><surname>Mccammon</surname><given-names>MR</given-names></name><name><surname>Hickner</surname><given-names>RC</given-names></name></person-group><article-title>Long- term exercise training in over weight adolescents improves plasma peptide YY and resistin</article-title><source>obesity (silver spring)</source><year>2009</year><volume>17</volume><issue>6</issue><fpage>1189</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">19247279</pub-id></element-citation></ref><ref id="b18-epj-05-623"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bravata</surname><given-names>DM</given-names></name><name><surname>Smith-Spangler</surname><given-names>C</given-names></name><name><surname>Sundaram</surname><given-names>V</given-names></name><name><surname>Gienger</surname><given-names>AL</given-names></name><name><surname>Lin</surname><given-names>N</given-names></name><name><surname>Lewis</surname><given-names>R</given-names></name><name><surname>Stave</surname><given-names>CD</given-names></name><name><surname>Olkin</surname><given-names>I</given-names></name><name><surname>Sirard</surname><given-names>JR</given-names></name></person-group><article-title>Using pedometers to increase physical activity and improve health: a systematic review</article-title><source>J American medical association (JAMA)</source><year>2007</year><comment>21</comment><volume>298</volume><issue>19</issue><fpage>2296</fpage><lpage>304</lpage></element-citation></ref><ref id="b19-epj-05-623"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steppan</surname><given-names>CM</given-names></name><name><surname>Bailey</surname><given-names>ST</given-names></name><name><surname>Bhat</surname><given-names>S</given-names></name><name><surname>Brown</surname><given-names>EJ</given-names></name><name><surname>Banerjee</surname><given-names>RR</given-names></name><name><surname>Wright</surname><given-names>CM</given-names></name><name><surname>Patel</surname><given-names>HR</given-names></name><name><surname>Ahima</surname><given-names>RS</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group><article-title>The hormone resistin links obesity to diabetes</article-title><source>Nature</source><year>2001</year><comment>18</comment><volume>409</volume><issue>6818</issue><fpage>307</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">11201732</pub-id></element-citation></ref><ref id="b20-epj-05-623"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hughes</surname><given-names>S</given-names></name></person-group><article-title>Novel cardiovascular risk factors</article-title><source>J cardiovasc Nurs</source><year>2003</year><volume>18</volume><issue>2</issue><fpage>131</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">12680572</pub-id></element-citation></ref><ref id="b21-epj-05-623"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goralski</surname><given-names>KB</given-names></name><name><surname>McCarthy</surname><given-names>TC</given-names></name><name><surname>Hanniman</surname><given-names>EA</given-names></name><name><surname>Zabel</surname><given-names>BA</given-names></name><name><surname>Butcher</surname><given-names>EC</given-names></name><name><surname>Parlee</surname><given-names>SD</given-names></name><name><surname>Muruganandan</surname><given-names>S</given-names></name><name><surname>Sinal</surname><given-names>CJ</given-names></name></person-group><article-title>Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism</article-title><source>J Biol Chem</source><year>2007</year><volume>282</volume><issue>38</issue><fpage>28175</fpage><lpage>88</lpage><pub-id pub-id-type="pmid">17635925</pub-id></element-citation></ref><ref id="b22-epj-05-623"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boskabadi</surname><given-names>MH</given-names></name><name><surname>Emad Zadeh</surname><given-names>M</given-names></name><name><surname>Hassan Zadeh</surname><given-names>AA</given-names></name><name><surname>Salimi</surname><given-names>N</given-names></name><name><surname>Haji Zadeh</surname><given-names>S</given-names></name></person-group><article-title>Study of the level of blood pressure in subjects older than eighteen years in Mashhad</article-title><source>Physiology Pharmacology J</source><year>2005</year><volume>2</volume><issue>9</issue><fpage>195</fpage><lpage>20</lpage></element-citation></ref><ref id="b23-epj-05-623"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>oberbach</surname><given-names>A</given-names></name><name><surname>Tonjes</surname><given-names>A</given-names></name><name><surname>Kloting</surname><given-names>N</given-names></name><name><surname>Fasshauer</surname><given-names>M</given-names></name><name><surname>Kratzsch</surname><given-names>J</given-names></name><name><surname>Busse</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Effect of a 4 week physical training program on plasma concentrations of inflammatory markers in patients with abnormal glucose tolerance</article-title><source>Eur J Endocrinol</source><year>2006</year><volume>154</volume><issue>4</issue><fpage>77</fpage><lpage>85</lpage></element-citation></ref><ref id="b24-epj-05-623"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kassapis</surname><given-names>C</given-names></name><name><surname>Thompson</surname><given-names>PD</given-names></name></person-group><article-title>The Effects of physical Activity on Serum C- Reactive Protein and Inflammatory Markers</article-title><source>J Am Coll Cardiol</source><year>2005</year><volume>45</volume><fpage>1563</fpage><lpage>1569</lpage><pub-id pub-id-type="pmid">15893167</pub-id></element-citation></ref><ref id="b25-epj-05-623"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>J</given-names></name><name><surname>Ren</surname><given-names>CX</given-names></name><name><surname>Qi</surname><given-names>YF</given-names></name><name><surname>Lou</surname><given-names>LX</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>LK</given-names></name><name><surname>Wang</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>C</given-names></name></person-group><article-title>Exercise training promotes expression of apelin and APJ of cardiovascular tissues in spontaneously hypertensive rats</article-title><source>Life Sci</source><year>2006</year><comment>15</comment><volume>79</volume><issue>12</issue><fpage>1153</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16674982</pub-id></element-citation></ref><ref id="b26-epj-05-623"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jessup</surname><given-names>JV</given-names></name><name><surname>Lowenthal</surname><given-names>DT</given-names></name><name><surname>Pollock</surname><given-names>ML</given-names></name><name><surname>Turner</surname><given-names>T</given-names></name></person-group><article-title>The effects of endurance exercise training on ambulatory blood pressure in normotensive older adults</article-title><source>Geriatr Nephrol</source><year>1998</year><volume>8</volume><issue>2</issue><fpage>103</fpage><lpage>9</lpage></element-citation></ref><ref id="b27-epj-05-623"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pescatello</surname><given-names>LS</given-names></name><name><surname>Franklin</surname><given-names>BA</given-names></name><name><surname>Fagard</surname><given-names>R</given-names></name><name><surname>Farquhar</surname><given-names>WB</given-names></name><name><surname>Kelley</surname><given-names>GA</given-names></name><name><surname>Ray</surname><given-names>CA</given-names></name></person-group><article-title>American College of Sports Medicine position stand. Exercise and hypertension</article-title><source>Med Sci Sports Exerc</source><year>2004</year><volume>36</volume><issue>3</issue><fpage>533</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">15076798</pub-id></element-citation></ref><ref id="b28-epj-05-623"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Roh</surname><given-names>SG</given-names></name><name><surname>Song</surname><given-names>SH</given-names></name><name><surname>Choi</surname><given-names>KC</given-names></name><name><surname>Katoh</surname><given-names>K</given-names></name><name><surname>Wittamer</surname><given-names>V</given-names></name><name><surname>Parmentier</surname><given-names>M</given-names></name><name><surname>Sasaki</surname><given-names>S</given-names></name></person-group><article-title>Chemerin--a new adipokine that modulates adipogenesis via its own receptor</article-title><source>Biochem Biophys Res Commun</source><year>2007</year><comment>3</comment><volume>362</volume><issue>4</issue><fpage>1013</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">17767914</pub-id></element-citation></ref><ref id="b29-epj-05-623"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>W</given-names></name><name><surname>Yu</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>W</given-names></name><name><surname>Luo</surname><given-names>M</given-names></name></person-group><article-title>Resistin increases lipid accumulation and CD36 expression in human macrophages</article-title><source>Biochem Biophys Res Commun</source><year>2006</year><comment>15</comment><volume>351</volume><issue>2</issue><fpage>376</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">17067553</pub-id></element-citation></ref><ref id="b30-epj-05-623"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jones</surname><given-names>TE</given-names></name><name><surname>Basilio</surname><given-names>JL</given-names></name><name><surname>Brophy</surname><given-names>PM</given-names></name><name><surname>Mccammon</surname><given-names>MR</given-names></name><name><surname>Hickner</surname><given-names>RC</given-names></name></person-group><article-title>Long- term exercise training in overweight a dolescents improves plasma peptide YY and resistin</article-title><source>obesity (silver spring)</source><year>2009</year><volume>17</volume><issue>G</issue><fpage>1189</fpage><lpage>950</lpage><pub-id pub-id-type="pmid">19247279</pub-id></element-citation></ref><ref id="b31-epj-05-623"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaser</surname><given-names>S</given-names></name><name><surname>Kaser</surname><given-names>A</given-names></name><name><surname>Sandhofer</surname><given-names>A</given-names></name><name><surname>Ebenbichler</surname><given-names>CF</given-names></name><name><surname>Tilg</surname><given-names>H</given-names></name><name><surname>Patsch</surname><given-names>JR</given-names></name></person-group><article-title>Resistin messenger-RNA expression is increased by proinflammatory cytokines in vitro</article-title><source>Biochem Biophys Res Commun</source><year>2003</year><comment>19</comment><volume>309</volume><issue>2</issue><fpage>286</fpage><lpage>90</lpage><pub-id pub-id-type="pmid">12951047</pub-id></element-citation></ref><ref id="b32-epj-05-623"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>KH</given-names></name><name><surname>Zhao</surname><given-names>L</given-names></name><name><surname>Moon</surname><given-names>Y</given-names></name><name><surname>Kang</surname><given-names>C</given-names></name><name><surname>Sul</surname><given-names>HS</given-names></name></person-group><article-title>Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity</article-title><source>Proc Natl Acad Sci U S A</source><year>2004</year><comment>27</comment><volume>101</volume><issue>17</issue><fpage>6780</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15090646</pub-id></element-citation></ref><ref id="b33-epj-05-623"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Konrad</surname><given-names>A</given-names></name><name><surname>Lehrke</surname><given-names>M</given-names></name><name><surname>Schachinger</surname><given-names>V</given-names></name><name><surname>Seibold</surname><given-names>F</given-names></name><name><surname>Stark</surname><given-names>R</given-names></name><name><surname>Ochsenk&#x000fc;hn</surname><given-names>T</given-names></name><name><surname>Parhofer</surname><given-names>KG</given-names></name><name><surname>G&#x000f6;ke</surname><given-names>B</given-names></name><name><surname>Broedl</surname><given-names>UC</given-names></name></person-group><article-title>Resistin is an inflammatory marker of inflammatory bowel disease in humans</article-title><source>Eur J Gastroenterol Hepatol</source><year>2007</year><volume>19</volume><issue>12</issue><fpage>1070</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">17998831</pub-id></element-citation></ref><ref id="b34-epj-05-623"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lehrke</surname><given-names>M</given-names></name><name><surname>Reilly</surname><given-names>MP</given-names></name><name><surname>Millington</surname><given-names>SC</given-names></name><name><surname>Iqbal</surname><given-names>N</given-names></name><name><surname>Rader</surname><given-names>DJ</given-names></name><name><surname>Lazar</surname><given-names>MA</given-names></name></person-group><article-title>An inflammatory cascade leading to hyperresistinemia in humans</article-title><source>PLoS Med</source><year>2004</year><volume>1</volume><issue>2</issue><fpage>e45</fpage><pub-id pub-id-type="pmid">15578112</pub-id></element-citation></ref><ref id="b35-epj-05-623"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moreau</surname><given-names>KL</given-names></name><name><surname>Degarmo</surname><given-names>R</given-names></name><name><surname>Langley</surname><given-names>J</given-names></name><name><surname>McMahon</surname><given-names>C</given-names></name><name><surname>Howley</surname><given-names>ET</given-names></name><name><surname>Bassett</surname><given-names>DR</given-names><suffix>Jr</suffix></name><name><surname>Thompson</surname><given-names>DL</given-names></name></person-group><article-title>Increasing daily walking lowers blood pressure in postmenopausal women</article-title><source>Med Sci Sports Exerc</source><year>2001</year><volume>33</volume><issue>11</issue><fpage>1825</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">11689731</pub-id></element-citation></ref><ref id="b36-epj-05-623"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ganderton</surname><given-names>L</given-names></name><name><surname>Jenkins</surname><given-names>S</given-names></name><name><surname>Gain</surname><given-names>K</given-names></name><name><surname>Fowler</surname><given-names>R</given-names></name><name><surname>Winship</surname><given-names>P</given-names></name><name><surname>Lunt</surname><given-names>D</given-names></name><name><surname>Gabbay</surname><given-names>E</given-names></name></person-group><article-title>Short term effects of exercise training on exercise capacity and quality of life in patients with pulmonary arterial hypertension: protocol for a randomised controlled trial</article-title><source>BMC Pulm Med</source><year>2011</year><volume>23</volume><comment>11</comment><fpage>25</fpage><pub-id pub-id-type="doi">10.1186/1471-2466-11-25</pub-id><pub-id pub-id-type="pmid">21600062</pub-id></element-citation></ref><ref id="b37-epj-05-623"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Crouse</surname><given-names>JH</given-names></name><name><surname>Crouse</surname><given-names>JR</given-names></name><name><surname>Goldbourt</surname><given-names>U</given-names></name><name><surname>Evans</surname><given-names>G</given-names></name><name><surname>Pinsky</surname><given-names>J</given-names></name><name><surname>Sharrett</surname><given-names>AR</given-names></name><name><surname>Sorlie</surname><given-names>P</given-names></name><name><surname>Riley</surname><given-names>W</given-names></name><name><surname>Heiss</surname><given-names>G</given-names></name></person-group><article-title>Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort</article-title><source>Stroke</source><year>1996</year><volume>27</volume><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">8553406</pub-id></element-citation></ref><ref id="b38-epj-05-623"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sell</surname><given-names>H</given-names></name><name><surname>Laurencikiene</surname><given-names>J</given-names></name><name><surname>Taube</surname><given-names>A</given-names></name><name><surname>Eckardt</surname><given-names>K</given-names></name><name><surname>Cramer</surname><given-names>A</given-names></name><name><surname>Horrighs</surname><given-names>A</given-names></name><name><surname>Arner</surname><given-names>P</given-names></name><name><surname>Eckel</surname><given-names>J</given-names></name></person-group><article-title>Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells</article-title><source>Diabetes</source><year>2009</year><volume>58</volume><issue>12</issue><fpage>2731</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">19720798</pub-id></element-citation></ref><ref id="b39-epj-05-623"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Saremi</surname><given-names>A</given-names></name><name><surname>Shavandi</surname><given-names>N</given-names></name><name><surname>Parastesh</surname><given-names>M</given-names></name><name><surname>Daneshmand</surname><given-names>H</given-names></name></person-group><article-title>Twelve-week aerobic training decreases chemerin level and improves cardiometabolic risk factors in over weight and obese men</article-title><source>Asian J Sports Med (A J M)</source><year>2010</year><volume>1</volume><issue>3</issue><fpage>151</fpage><lpage>8</lpage></element-citation></ref><ref id="b40-epj-05-623"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gao</surname><given-names>X</given-names></name><name><surname>Mi</surname><given-names>S</given-names></name><name><surname>Zhang</surname><given-names>F</given-names></name><name><surname>Gong</surname><given-names>F</given-names></name><name><surname>Lai</surname><given-names>Y</given-names></name><name><surname>Gao</surname><given-names>F</given-names></name><name><surname>Zhang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Tao</surname><given-names>H</given-names></name></person-group><article-title>Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis</article-title><source>Cardiovasc Diabetol</source><year>2011</year><volume>7</volume><comment>10</comment><fpage>87</fpage><pub-id pub-id-type="pmid">21981776</pub-id></element-citation></ref><ref id="b41-epj-05-623"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Staffileno</surname><given-names>BA</given-names></name><name><surname>Minnick</surname><given-names>A</given-names></name><name><surname>Coke</surname><given-names>LA</given-names></name><name><surname>Hollenberg</surname><given-names>SM</given-names></name></person-group><article-title>Blood pressure responses to lifestyle physical activity among young, hypertension-prone African-American women</article-title><source>J CardiovascNurs</source><year>2007</year><volume>22</volume><issue>2</issue><fpage>107</fpage><lpage>17</lpage></element-citation></ref><ref id="b42-epj-05-623"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Levenstein</surname><given-names>S</given-names></name><name><surname>Smith</surname><given-names>MW</given-names></name><name><surname>Kaplan</surname><given-names>GA</given-names></name></person-group><article-title>Psychosocial predictors of hypertension in men and women</article-title><source>Arch Intern Med</source><year>2001</year><comment>28</comment><volume>161</volume><issue>10</issue><fpage>1341</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">11371264</pub-id></element-citation></ref><ref id="b43-epj-05-623"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pauletto</surname><given-names>P</given-names></name><name><surname>Palatini</surname><given-names>P</given-names></name><name><surname>DaRos</surname><given-names>S</given-names></name><name><surname>Pagliara</surname><given-names>V</given-names></name><name><surname>Santipolo</surname><given-names>N</given-names></name><name><surname>Baccillieri</surname><given-names>S</given-names></name><name><surname>Casiglia</surname><given-names>E</given-names></name><name><surname>Mormino</surname><given-names>P</given-names></name><name><surname>Pessina</surname><given-names>AC</given-names></name></person-group><article-title>Factors underlying the increase in carotid intima&#x02013;media thickness in borderline hypertensives</article-title><source>Arterioscl Thromb Vasc Biol</source><year>1999</year><volume>19</volume><issue>5</issue><fpage>1231</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">10323774</pub-id></element-citation></ref></ref-list></back><floats-group><table-wrap id="t1-epj-05-623" position="float"><label>Table 1.</label><caption><p>Mean and standard deviation of the physiological characteristics of subjects in each group (n=10, p &#x0003c;0.05)</p></caption><table frame="box" rules="all"><thead><tr><th colspan="2" valign="bottom" align="left" rowspan="1">Groups</th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Age (year)</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Weight (kg)</bold></th><th valign="bottom" align="left" rowspan="1" colspan="1"><bold>Height (cm)</bold></th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Exercise</td><td valign="top" align="left" rowspan="1" colspan="1">Mean &#x000b1; S.D</td><td valign="top" align="left" rowspan="1" colspan="1">54 &#x000b1; 3.75</td><td valign="top" align="left" rowspan="1" colspan="1">29.74 &#x000b1; 10.9</td><td valign="top" align="left" rowspan="1" colspan="1">22.158 &#x000b1; 51.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Control</td><td valign="top" align="left" rowspan="1" colspan="1">Mean &#x000b1; S.D</td><td valign="top" align="left" rowspan="1" colspan="1">53.22 &#x000b1; 4.66</td><td valign="top" align="left" rowspan="1" colspan="1">44.73 &#x000b1; 38.9</td><td valign="top" align="left" rowspan="1" colspan="1">56.157 &#x000b1; 88.1</td></tr></tbody></table></table-wrap><table-wrap id="t2-epj-05-623" position="float"><label>Table 2.</label><caption><p>Statistical description of chemerin and Resistin concentrations Mean (pg ml) in the exercise and control groups in terms of measures of central tendency and dispersion</p></caption><table frame="box" rules="all"><thead><tr><th colspan="2" rowspan="2" valign="top" align="left">Statistical indices Groups</th><th colspan="2" valign="top" align="left" rowspan="1"><bold>Mean</bold></th><th colspan="2" valign="top" align="left" rowspan="1"><bold>Standard deviation</bold></th></tr><tr><th valign="top" align="left" rowspan="1" colspan="1">After</th><th valign="top" align="left" rowspan="1" colspan="1">Before</th><th valign="top" align="left" rowspan="1" colspan="1">After</th><th valign="top" align="left" rowspan="1" colspan="1">Before</th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="left" colspan="1">Chemerin</td><td valign="top" align="left" rowspan="1" colspan="1">Exercise</td><td valign="top" align="left" rowspan="1" colspan="1">250.66</td><td valign="top" align="left" rowspan="1" colspan="1">337.48</td><td valign="top" align="left" rowspan="1" colspan="1">31.22</td><td valign="top" align="left" rowspan="1" colspan="1">35.56</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Control</td><td valign="top" align="left" rowspan="1" colspan="1">343.70</td><td valign="top" align="left" rowspan="1" colspan="1">348.99</td><td valign="top" align="left" rowspan="1" colspan="1">31.89</td><td valign="top" align="left" rowspan="1" colspan="1">29.61</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Resistin</td><td valign="top" align="left" rowspan="1" colspan="1">Exercise</td><td valign="top" align="left" rowspan="1" colspan="1">2.22</td><td valign="top" align="left" rowspan="1" colspan="1">3.13</td><td valign="top" align="left" rowspan="1" colspan="1">0.84</td><td valign="top" align="left" rowspan="1" colspan="1">0.63</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Control</td><td valign="top" align="left" rowspan="1" colspan="1">3.02</td><td valign="top" align="left" rowspan="1" colspan="1">3.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.57</td><td valign="top" align="left" rowspan="1" colspan="1">0.62</td></tr></tbody></table></table-wrap><table-wrap id="t3-epj-05-623" position="float"><label>Table 3.</label><caption><p>Independent t-test results to evaluate differences between Resistin concentrations before and after exercise and Chemerin concentration before and after exercise</p></caption><table frame="box" rules="all"><thead><tr><th colspan="3" valign="top" align="left" rowspan="1">Statistical indices Groups</th><th valign="top" align="left" rowspan="1" colspan="1">Mean</th><th valign="top" align="left" rowspan="1" colspan="1">Standard deviation</th><th valign="top" align="left" rowspan="1" colspan="1">Df<xref ref-type="table-fn" rid="tfn1-epj-05-623"><sup>*</sup></xref></th><th valign="top" align="left" rowspan="1" colspan="1">t value</th><th valign="top" align="left" rowspan="1" colspan="1">Table&#x02019;s t</th><th valign="top" align="left" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="4" valign="top" align="left" colspan="1">Chemerin</td><td rowspan="2" valign="top" align="left" colspan="1">Exercise</td><td valign="top" align="left" rowspan="1" colspan="1">Before exercise</td><td valign="top" align="left" rowspan="1" colspan="1">337.48</td><td valign="top" align="left" rowspan="1" colspan="1">35.56</td><td rowspan="2" valign="top" align="left" colspan="1">6</td><td rowspan="2" valign="top" align="left" colspan="1">10.41</td><td rowspan="2" valign="top" align="left" colspan="1">2.44</td><td rowspan="2" valign="top" align="left" colspan="1">0.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After exercise</td><td valign="top" align="left" rowspan="1" colspan="1">250.66</td><td valign="top" align="left" rowspan="1" colspan="1">31.22</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Control</td><td valign="top" align="left" rowspan="1" colspan="1">Before exercise</td><td valign="top" align="left" rowspan="1" colspan="1">348.99</td><td valign="top" align="left" rowspan="1" colspan="1">29.61</td><td rowspan="2" valign="top" align="left" colspan="1">6</td><td rowspan="2" valign="top" align="left" colspan="1">1.60</td><td rowspan="2" valign="top" align="left" colspan="1">2.44</td><td rowspan="2" valign="top" align="left" colspan="1">0.160</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After exercise</td><td valign="top" align="left" rowspan="1" colspan="1">343.70</td><td valign="top" align="left" rowspan="1" colspan="1">31.89</td></tr><tr><td rowspan="4" valign="top" align="left" colspan="1">Resistin</td><td rowspan="2" valign="top" align="left" colspan="1">Exercise</td><td valign="top" align="left" rowspan="1" colspan="1">Before exercise</td><td valign="top" align="left" rowspan="1" colspan="1">3.13</td><td valign="top" align="left" rowspan="1" colspan="1">0.63</td><td rowspan="2" valign="top" align="left" colspan="1">6</td><td rowspan="2" valign="top" align="left" colspan="1">2.42</td><td rowspan="2" valign="top" align="left" colspan="1">2.44</td><td rowspan="2" valign="top" align="left" colspan="1">0.051</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After exercise</td><td valign="top" align="left" rowspan="1" colspan="1">2.22</td><td valign="top" align="left" rowspan="1" colspan="1">0.84</td></tr><tr><td rowspan="2" valign="top" align="left" colspan="1">Control</td><td valign="top" align="left" rowspan="1" colspan="1">Before exercise</td><td valign="top" align="left" rowspan="1" colspan="1">3.02</td><td valign="top" align="left" rowspan="1" colspan="1">0.62</td><td rowspan="2" valign="top" align="left" colspan="1">6</td><td rowspan="2" valign="top" align="left" colspan="1">&#x02212; 0.475</td><td rowspan="2" valign="top" align="left" colspan="1">2.44</td><td rowspan="2" valign="top" align="left" colspan="1">0.652</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">After exercise</td><td valign="top" align="left" rowspan="1" colspan="1">3.03</td><td valign="top" align="left" rowspan="1" colspan="1">0.57</td></tr></tbody></table><table-wrap-foot><fn id="tfn1-epj-05-623"><label>*</label><p>df: Degree of freedom</p></fn></table-wrap-foot></table-wrap><table-wrap id="t4-epj-05-623" position="float"><label>Table 4.</label><caption><p>The comparison of chemerin and Resistin control and exercise group</p></caption><table frame="box" rules="all"><thead><tr><th colspan="2" valign="top" align="left" rowspan="1">Statistical indices Groups</th><th valign="top" align="left" rowspan="1" colspan="1">Mean</th><th valign="top" align="left" rowspan="1" colspan="1">Standard deviation</th><th valign="top" align="left" rowspan="1" colspan="1">Differences in the mean</th><th valign="top" align="left" rowspan="1" colspan="1">Df<xref ref-type="table-fn" rid="tfn2-epj-05-623"><sup>*</sup></xref></th><th valign="top" align="left" rowspan="1" colspan="1">t value</th><th valign="top" align="left" rowspan="1" colspan="1">Table&#x02019;s t</th><th valign="top" align="left" rowspan="1" colspan="1">P value</th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="left" colspan="1">Chemerin</td><td valign="top" align="left" rowspan="1" colspan="1">Exercise</td><td valign="top" align="left" rowspan="1" colspan="1">37.2</td><td valign="top" align="left" rowspan="1" colspan="1">14.14</td><td rowspan="2" valign="top" align="left" colspan="1">35.27</td><td rowspan="2" valign="top" align="left" colspan="1">1</td><td rowspan="2" valign="top" align="left" colspan="1">4.15</td><td rowspan="2" valign="top" align="left" colspan="1">2.14</td><td rowspan="2" valign="top" align="left" colspan="1">0.000</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Control</td><td valign="top" align="left" rowspan="1" colspan="1">293.93</td><td valign="top" align="left" rowspan="1" colspan="1">13.7</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Resistin</td><td valign="top" align="left" rowspan="1" colspan="1">Exercise</td><td valign="top" align="left" rowspan="1" colspan="1">3.02</td><td valign="top" align="left" rowspan="1" colspan="1">0.44</td><td valign="top" align="left" rowspan="1" colspan="1">0.52</td><td valign="top" align="left" rowspan="1" colspan="1">1</td><td valign="top" align="left" rowspan="1" colspan="1">1.15</td><td valign="top" align="left" rowspan="1" colspan="1">2.14</td><td valign="top" align="left" rowspan="1" colspan="1">0.130</td></tr></tbody></table><table-wrap-foot><fn id="tfn2-epj-05-623"><label>*</label><p>df: Degree of freedom</p></fn></table-wrap-foot></table-wrap><table-wrap id="t5-epj-05-623" position="float"><label>Table 5.</label><caption><p>Pearson correlation between Resistin and chemerin</p></caption><table frame="box" rules="all"><thead><tr><th colspan="2" valign="top" align="left" rowspan="1">Pearson correlation coefficient Group</th><th valign="top" align="left" rowspan="1" colspan="1">r</th><th valign="top" align="left" rowspan="1" colspan="1">P</th><th valign="top" align="left" rowspan="1" colspan="1">R<sup>2</sup></th><th valign="top" align="left" rowspan="1" colspan="1">P&#x0003c;0.05</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Exercise Group</td><td valign="top" align="left" rowspan="1" colspan="1">Resistin - chemerin</td><td valign="top" align="left" rowspan="1" colspan="1">0.033</td><td valign="top" align="left" rowspan="1" colspan="1">0.944</td><td valign="top" align="left" rowspan="1" colspan="1">0.0008</td><td valign="top" align="left" rowspan="1" colspan="1">0.666</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Control group</td><td valign="top" align="left" rowspan="1" colspan="1">Resistin - chemerin</td><td valign="top" align="left" rowspan="1" colspan="1">&#x02212;0.513</td><td valign="top" align="left" rowspan="1" colspan="1">0.239</td><td valign="top" align="left" rowspan="1" colspan="1">0.263</td><td valign="top" align="left" rowspan="1" colspan="1">0.666</td></tr></tbody></table></table-wrap></floats-group></article>